In 1967 Kay et al postulated that some cases of unexplained pulmonary hypertension might be due to the ingestion of drugs or other toxic substances.' This concept, later termed dietary pulmonary hypertension,23 was advanced following the observation that the oral administration to rats of the pyrrolizidine alkaloid monocrotaline produced severe pulmonary hypertension.' There are no reports of pyrrolizidine alkaloids causing pulmonary hypertension in human subjects, but there have been two epidemics ofpulmonary hypertension caused by the ingestion of other substances, and several reports of pulmonary hypertension associated with the administration of drugs (table) . The two epidemics of pulmonary hypertension were related to the ingestion of an appetite suppressing drug aminorex,4 and to the ingestion of denatured rapeseed oil.5 Pulmonary hypertension has also been reported in two obese patients taking phenformin. Crotalaria spectabilis Crotalaria spectabilis is indigenous to India but is now widely scattered throughout the tropics and subtropics of both hemispheres." The stems, leaves, and seeds contain the pyrrolizidine alkaloid monocrotaline which is toxic to a wide range of animals including cattle, pigs, hens, turkeys, monkeys, and rats."
In 1967 Kay et al postulated that some cases of unexplained pulmonary hypertension might be due to the ingestion of drugs or other toxic substances.' This concept, later termed dietary pulmonary hypertension,23 was advanced following the observation that the oral administration to rats of the pyrrolizidine alkaloid monocrotaline produced severe pulmonary hypertension.' There are no reports of pyrrolizidine alkaloids causing pulmonary hypertension in human subjects, but there have been two epidemics ofpulmonary hypertension caused by the ingestion of other substances, and several reports of pulmonary hypertension associated with the administration of drugs (table) . The two epidemics of pulmonary hypertension were related to the ingestion of an appetite suppressing drug aminorex,4 and to the ingestion of denatured rapeseed oil.5 Pulmonary hypertension has also been reported in two obese patients taking phenformin.6 Severe pulmonary hypertension associated with haemolytic anaemia and renal failure occurred in a 46 year old man with carcinoma of the colon who was treated with mitomycin.7 Pulmonary veno-occlusive disease has been described in patients receiving chemotherapy with BCNU5 and bleomycin alone,9 or in combination with mitomycin and cisplatin,'°or mitomycin, cisplatin and vinblastine."1 The effects of pyrrolizidine alkaloids, anorexigens, L-tryptophan, and toxic oil on the pulmonary vasculature are considered in the following review.
Pyrrolozidine alkaloids and the pulmonary circulation Alkaloids are plant constituents other than simple amines which contain a basic nitrogen atom. They occur widely and are present in approximately 5% of all plant species. ' Senecio jacobaea This is the common ragwort plant whic ers have long recognised as being toxic (fig 2) . Its seeds and leaves contain 1 rolizidine alkaloids seneciphylline, sene jacobine, jaconine, jacoline, and jacoz is available in some health food stoi dried, chopped form, which is made infusion to cure various ailments. WI are given a diet adulterated with pc dried Senecio jacobaea they develop rig ricular hypertrophy, thickening of t monary trunk, medial hypertrophy of n pulmonary arteries, and muscularisatic pulmonary arterioles. 22 Pure seneciphy] been shown to induce right ver hypertrophy and medial hypertrophy monary arteries in rats.23
MECHANISM OF PULMONARY TOXICITY C PYRROLIZIDINE ALKALOIDS
The mechanism by which the pyrrc alkaloids produce pulmonary hypertei laboratory animals is not clear.2425 1 considerable variation in the suscepti animal species to the pulmonary hype effects of monocrotaline.26 Pulmonarr tension has been described in rats an( monkeys given monocrotaline,27 but mice, rabbits, and hamsters are relatively resistant to its pulmonary hypertensive effects, and dogs are only occasionally susceptible.26 One ofthe most intriguing problems is the latent period of several days which elapses between the administration of the alkaloid and the development of pulmonary vascular lesions. Endothelial injury may be an early, or perhaps the earliest, event which occurs in the lungs after the administration of monocrotaline.2829 The sequence of events in rats following a single injection of monocrotaline appears to be as follows: endothelial injury is detected by electron microscopy at four days,28 muscularisation ofpulmonary arterioles and medial hypertrophy of muscular pulmonary arteries occurs at seven days, pulmonary hypertension is detectable at 10 days, and right ventricular hypertrophy is present at 12 days. 30 There is evidence that the pyrrolizidine alkaloids themselves are not toxic substances, but that they are dehydrogenated in the liver to produce highly reactive pyrrole derivatives, which may then be transported to the lungs. It tryptamine,33 34 44 The clinical and pathological features of hepatic veno-occlusive disease are well described elsewhere,45 and are outside the scope of this paper. Hypertensive pulmonary vascular disease has never been described in human cases of hepatic veno-occlusive disease. The pulmonary arteries and veins in these patients are normal.46 It is not clear why human pulmonary arteries and veins are apparently unaffected by the pyrrolizidine alkaloids when they exert such toxic effects on the small hepatic veins. When injections of monocrotaline were given to two groups of stumptail monkeys aged one month and 15 months, respectively, the younger animals developed pulmonary hypertension while the older animals got hepatic veno-occlusive disease.27 It was suggested that the different responses of infant and older monkeys were related to differences in hepatic microsomal enzyme activity. It was hypothesised that the enzyme systems associated with the production of metabolites which are toxic to the lung were better developed in the infant than in the older animals. It should be noted, however, that when children ingest pyrrolizidine alkaloids in bush tea tween the logarithm of the risk of developing pulmonary hypertension and the number of aminorex tablets ingested. Specifically, after the ingestion of more than eight packs of aminorex tablets there was a 10% risk of developing the disease. Women were affected four times more frequently than men, and the onset of symptoms of pulmonary hypertension generally occurred 12 months after the commencement of aminorex therapy. There was no correlation between the total amount of aminorex ingested and the degree of pulmonary hypertension. In a study of 17 fatal cases of pulmonary hypertension following aminorex ingestion pulmonary arteriopathy with plexiform lesions was present in five cases (fig 3) . There were 11 cases of pulmonary arteriopathy with medial hypertrophy and intimal fibrosis (fig 4) , and one case of thrombotic pulmonary arteriopathy. 46 Experience during the last 20 years has shown that the prognosis of aminorex-related pulmonary hypertension is better than that of unexplained pulmonary hypertension, and depends on the age of the patient at the time of the anorexic treatment, the initial severity of the pulmonary hypertension and right ventricular failure, and the amount of anorexigen ingested. 50 In some patients withdrawal of aminorex has led to partial remission of the pulmonary hypertension. 50 In a 15 year follow up of a female patient with aminorex-related pulmonary hypertension a fusiform aneurysm of the pulmonary trunk was observed.5'
The mechanism whereby aminorex produces pulmonary hypertension is not clear. In experimental studies on animals, acute and subacute administration of aminorex leads to a significant, but transient, increase in pulmonary arterial pressure and in pulmonary vascular resistance in most of the species tested.50 It has not proved possible, however, to induce chronic pulmonary hypertension or pulmonary vascular disease after chronic administration of the drug. 4 (fig 6) . The intimal proliferation was associated with narrowing or even occlusion ofthe lumen. The endothelial cells were swollen and there was a perivascular infiltrate of lymphocytes, plasma cells, histiocytes, and eosinophils.65 One report mentioned plexiform lesions, but the single illustration in this paper is not convincing.TM The toxic oil syndrome bears some resemblance to the esosinophilia-myalgia syndrome associated with L-tryptophan ingestion."
